Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Showing 1-25 of 229 citing articles:

MOG-IgG in NMO and related disorders: a multicenter study of 50 patients. Part 2: Epidemiology, clinical presentation, radiological and laboratory features, treatment responses, and long-term outcome
Sven Jarius, Klemens Ruprecht, Ingo Kleiter, et al.
Journal of Neuroinflammation (2016) Vol. 13, Iss. 1
Open Access | Times Cited: 823
MOG encephalomyelitis: international recommendations on diagnosis and antibody testing
Sven Jarius, Friedemann Paul, Orhan Aktaş, et al.
Journal of Neuroinflammation (2018) Vol. 15, Iss. 1
Open Access | Times Cited: 665
Myelin oligodendrocyte glycoprotein antibodies in neurological disease
Markus Reindl, Patrick Waters
Nature Reviews Neurology (2018) Vol. 15, Iss. 2, pp. 89-102
Closed Access | Times Cited: 520
MOG-IgG in NMO and related disorders: a multicenter study of 50 patients. Part 1: Frequency, syndrome specificity, influence of disease activity, long-term course, association with AQP4-IgG, and origin
Sven Jarius, Klemens Ruprecht, Ingo Kleiter, et al.
Journal of Neuroinflammation (2016) Vol. 13, Iss. 1
Open Access | Times Cited: 398
Myelin Oligodendrocyte Glycoprotein Antibody–Positive Optic Neuritis: Clinical Characteristics, Radiologic Clues, and Outcome
John J. Chen, Eoin P. Flanagan, Jiraporn Jitprapaikulsan, et al.
American Journal of Ophthalmology (2018) Vol. 195, pp. 8-15
Open Access | Times Cited: 345
Neuromyelitis optica
Sven Jarius, Friedemann Paul, Brian G. Weinshenker, et al.
Nature Reviews Disease Primers (2020) Vol. 6, Iss. 1
Closed Access | Times Cited: 338
Neuromyelitis Spectrum Disorders
Brian G. Weinshenker, Dean M. Wingerchuk
Mayo Clinic Proceedings (2017) Vol. 92, Iss. 4, pp. 663-679
Open Access | Times Cited: 262
MOG-IgG in NMO and related disorders: a multicenter study of 50 patients. Part 3: Brainstem involvement - frequency, presentation and outcome
Sven Jarius, Ingo Kleiter, Klemens Ruprecht, et al.
Journal of Neuroinflammation (2016) Vol. 13, Iss. 1
Open Access | Times Cited: 234
Neurological update: MOG antibody disease
Ray Wynford‐Thomas, Anu Jacob, Valentina Tomassini
Journal of Neurology (2018) Vol. 266, Iss. 5, pp. 1280-1286
Open Access | Times Cited: 220
Myelin Oligodendrocyte Glycoprotein: Deciphering a Target in Inflammatory Demyelinating Diseases
Patrick Peschl, Monika Bradl, Romana Höftberger, et al.
Frontiers in Immunology (2017) Vol. 8
Open Access | Times Cited: 212
Diagnosis and Treatment of NMO Spectrum Disorder and MOG-Encephalomyelitis
Nadja Borisow, Masahiro Mori, Satoshi Kuwabara, et al.
Frontiers in Neurology (2018) Vol. 9
Open Access | Times Cited: 209
MOG-IgG-Associated Optic Neuritis, Encephalitis, and Myelitis: Lessons Learned From Neuromyelitis Optica Spectrum Disorder
Giordani Rodrigues dos Passos, Luana Michelli de Oliveira, Bruna Klein da Costa, et al.
Frontiers in Neurology (2018) Vol. 9
Open Access | Times Cited: 187
MOG antibody disease: A review of MOG antibody seropositive neuromyelitis optica spectrum disorder
Ram Narayan, Alexandra Simpson, Katelyn Fritsche, et al.
Multiple Sclerosis and Related Disorders (2018) Vol. 25, pp. 66-72
Closed Access | Times Cited: 175
Optic neuritis and autoimmune optic neuropathies: advances in diagnosis and treatment
Jeffrey L. Bennett, Fiona Costello, John J. Chen, et al.
The Lancet Neurology (2022) Vol. 22, Iss. 1, pp. 89-100
Closed Access | Times Cited: 129
Update on the diagnosis and treatment of neuromyelits optica spectrum disorders (NMOSD) – revised recommendations of the Neuromyelitis Optica Study Group (NEMOS). Part I: Diagnosis and differential diagnosis
Sven Jarius, Orhan Aktaş, Ilya Ayzenberg, et al.
Journal of Neurology (2023) Vol. 270, Iss. 7, pp. 3341-3368
Open Access | Times Cited: 111
Defining distinct features of anti-MOG antibody associated central nervous system demyelination
Martin S. Weber, Tobias Derfuß, Imke Metz, et al.
Therapeutic Advances in Neurological Disorders (2018) Vol. 11
Open Access | Times Cited: 152
Cerebrospinal fluid findings in patients with myelin oligodendrocyte glycoprotein (MOG) antibodies. Part 1: Results from 163 lumbar punctures in 100 adult patients
Sven Jarius, Hannah Pellkofer, Nadja Siebert, et al.
Journal of Neuroinflammation (2020) Vol. 17, Iss. 1
Open Access | Times Cited: 132
Microstructural visual system changes in AQP4-antibody–seropositive NMOSD
Frederike Cosima Oertel, Joseph Kuchling, Hanna Zimmermann, et al.
Neurology Neuroimmunology & Neuroinflammation (2017) Vol. 4, Iss. 3
Open Access | Times Cited: 125
The MRZ reaction as a highly specific marker of multiple sclerosis: re-evaluation and structured review of the literature
Sven Jarius, Peter Eichhorn, Diego Franciotta, et al.
Journal of Neurology (2016) Vol. 264, Iss. 3, pp. 453-466
Closed Access | Times Cited: 119
Vitamin D in the prevention, prediction and treatment of neurodegenerative and neuroinflammatory diseases
Priscilla Bäcker-Koduah, Friedemann Paul, Jan-Markus Dörr
The EPMA Journal (2017) Vol. 8, Iss. 4, pp. 313-325
Open Access | Times Cited: 117
Aquaporin-4 and Myelin Oligodendrocyte Glycoprotein Autoantibody Status Predict Outcome of Recurrent Optic Neuritis
Jiraporn Jitprapaikulsan, John J. Chen, Eoin P. Flanagan, et al.
Ophthalmology (2018) Vol. 125, Iss. 10, pp. 1628-1637
Open Access | Times Cited: 108
Interleukin-6 Receptor Blockade in Treatment-Refractory MOG-IgG–Associated Disease and Neuromyelitis Optica Spectrum Disorders
Marius Ringelstein, Ilya Ayzenberg, Gero Lindenblatt, et al.
Neurology Neuroimmunology & Neuroinflammation (2021) Vol. 9, Iss. 1
Open Access | Times Cited: 102
Myelin oligodendrocyte glycoprotein antibodies: How clinically useful are they?
Markus Reindl, Sven Jarius, Kevin Rostásy, et al.
Current Opinion in Neurology (2017) Vol. 30, Iss. 3, pp. 295-301
Closed Access | Times Cited: 99
Severe structural and functional visual system damage leads to profound loss of vision-related quality of life in patients with neuromyelitis optica spectrum disorders
Felix Schmidt, Hanna Zimmermann, Janine Mikolajczak, et al.
Multiple Sclerosis and Related Disorders (2016) Vol. 11, pp. 45-50
Closed Access | Times Cited: 98
E.U. paediatric MOG consortium consensus: Part 5 – Treatment of paediatric myelin oligodendrocyte glycoprotein antibody-associated disorders
Arlette L. Bruijstens, Eva‐Maria Wendel, Christian Lechner, et al.
European Journal of Paediatric Neurology (2020) Vol. 29, pp. 41-53
Open Access | Times Cited: 97
Page 1 - Next Page

Scroll to top